Four Thought Financial, LLC Blueprint Medicines Corp Transaction History

Four Thought Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$45.23 - $70.15 $13,795 - $21,395	-305 Closed	0 $0
Q2 2021 Nov 12, 2021	SELL	$82.78 - $101.0 $993 - $1,212	-12 Reduced 3.79%	305 $26,000
Q1 2021 Nov 12, 2021	SELL	$90.71 - $108.28 $1,451 - $1,732	-16 Reduced 4.8%	317 $30,000
Q4 2020 Nov 12, 2021	BUY	$92.08 - $124.48 $30,662 - $41,451	333 New	333 $37,000

379

61.5M

1.6M

1.41M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $4.93B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial, LLC with notifications on news.